Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia. [electronic resource]
Producer: 20070716Description: 612-8 p. digitalISSN:- 1592-8721
- Adolescent
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Basic Helix-Loop-Helix Transcription Factors -- genetics
- Benzamides
- Biomarkers, Tumor -- blood
- Clinical Trials as Topic -- statistics & numerical data
- Cohort Studies
- Combined Modality Therapy
- Female
- Fusion Proteins, bcr-abl -- blood
- Gene Deletion
- Gene Rearrangement, B-Lymphocyte
- Gene Rearrangement, T-Lymphocyte
- Hematopoietic Stem Cell Transplantation
- Humans
- Imatinib Mesylate
- Kaplan-Meier Estimate
- Kinetics
- Leukemia-Lymphoma, Adult T-Cell -- blood
- Male
- Middle Aged
- Multicenter Studies as Topic
- Myeloid-Lymphoid Leukemia Protein -- blood
- Neoplasm, Residual
- Oncogene Proteins, Fusion -- blood
- Piperazines -- administration & dosage
- Polymerase Chain Reaction
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma -- blood
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- blood
- Proto-Oncogene Proteins -- genetics
- Pyrimidines -- administration & dosage
- Remission Induction
- Risk
- Survival Analysis
- Survival Rate
- T-Cell Acute Lymphocytic Leukemia Protein 1
- Translocation, Genetic
- Transplantation Conditioning
- Transplantation, Homologous
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.